Tobias Ackermann

Tobias Ackermann

Auto-generated profile, based on publicly available information

Tobias Ackermann

European Research Institute for the Biology of Ageing (ERIBA), University Medical Center Groningen, University of Groningen, 9700 AD Groningen, the Netherlands

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2019 in Science Advances
Verified
Journal Article
Open access
PDF file
JVJohan Vande Voorde
Johan Vande Voorde
TATobias Ackermann
Tobias Ackermann
NPNadja Pfetzer
Nadja Pfetzer
DSDavid Sumpton
David Sumpton
GMGillian Mackay
Gillian Mackay
STSaverio Tardito
Saverio Tardito
Plasmax, a physiological cell culture medium, prevents metabolic artifacts imposed on cancer cells by commonly used media.

10 January 2013 in Endocrinology
Verified
Journal Article
Closed access
SHSigrun Horn
Sigrun Horn
SKSimone Kersseboom
Simone Kersseboom
SMSteffen Mayerl
Steffen Mayerl
JMJulia Müller
Julia Müller
CGClaudia Groba
Claudia Groba
HHHeike Heuer
Heike Heuer
The monocarboxylate transporter 8 (MCT8) plays a critical role in mediating the uptake of thyroid hormones (THs) into the brain. In patients, inactivating mutations in the MCT8 gene are associated with a severe form of psychomotor retardation and abnormal serum TH levels. Here, we evaluate the therapeutic potential of the TH analog 3,5,3′,5′-tetraiodothyroacetic acid (tetrac) as a replacement for T4 in brain development. Using COS1 cells transfected with TH transporter and deiodinase constructs, we could show that tetrac, albeit not being transported by MCT8, can be metabolized to the TH receptor active compound 3,3′,5-triiodothyroacetic acid (triac) by type 2 deiodinase and inactivated by type 3 deiodinase. Triac in turn is capable of replacing T3 in primary murine cerebellar cultures where it potently stimulates Purkinje cell development. In vivo effects of tetrac were assessed in congenital hypothyroid Pax8-knockout (KO) and Mct8/Pax8 double-KO mice as well as in Mct8-KO and wild-type animals after daily injection of tetrac (400 ng/g body weight) during the first postnatal weeks. This treatment was sufficient to promote TH-dependent neuronal differentiation in the cerebellum, cerebral cortex, and striatum but was ineffective in suppressing hypothalamic TRH expression. In contrast, TSH transcript levels in the pituitary were strongly down-regulated in response to tetrac. Based on our findings we propose that tetrac administration offers the opportunity to provide neurons during the postnatal stage with a potent TH receptor agonist, thereby eventually reducing the neurological damage in patients with MCT8 mutations without deteriorating the thyrotoxic situation in peripheral tissues.

25 June 2015 in EMBO Reports
Verified
Journal Article
Open access
PDF file
LZLaura M Zidek
Laura M Zidek
TATobias Ackermann
Tobias Ackermann
GHGötz Hartleben
Götz Hartleben
SESabrina Eichwald
Sabrina Eichwald
GKGertrud Kortman
Gertrud Kortman
CCCornelis F Calkhoven
Cornelis F Calkhoven
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

1 January 2018 in Cell Reports
Verified
Journal Article
Open access
MZMohamad A. Zaini
Mohamad A. Zaini
CMChristine Müller
Christine Müller
TJTristan V. de Jong
Tristan V. de Jong
TATobias Ackermann
Tobias Ackermann
GHGötz Hartleben
Götz Hartleben
CCCornelis F. Calkhoven
Cornelis F. Calkhoven
Cellular metabolism is a tightly controlled process in which the cell adapts fluxes through metabolic pathways in response to changes in nutrient supply. Among the transcription factors that regulate gene expression and thereby cause changes in cellular metabolism is the basic leucine-zipper (bZIP) transcription factor CCAAT/enhancer-binding protein alpha (C/EBPα). Protein lysine acetylation is a key post-translational modification (PTM) that integrates cellular metabolic cues with other physiological processes. Here, we show that C/EBPα is acetylated by the lysine acetyl transferase (KAT) p300 and deacetylated by the lysine deacetylase (KDAC) sirtuin1 (SIRT1). SIRT1 is activated in times of energy demand by high levels of nicotinamide adenine dinucleotide (NAD+) and controls mitochondrial biogenesis and function. A hypoacetylated mutant of C/EBPα induces the transcription of mitochondrial genes and results in increased mitochondrial respiration. Our study identifies C/EBPα as a key mediator of SIRT1-controlled adaption of energy homeostasis to changes in nutrient supply.

4 June 2018 in eLife
Verified
Journal Article
Open access
CMChristine Müller
Christine Müller
LZLaura M Zidek
Laura M Zidek
TATobias Ackermann
Tobias Ackermann
TJTristan de Jong
Tristan de Jong
PLPeng Liu
Peng Liu
CCCornelis F Calkhoven
Cornelis F Calkhoven
Ageing is associated with physical decline and the development of age-related diseases such as metabolic disorders and cancer. Few conditions are known that attenuate the adverse effects of ageing, including calorie restriction (CR) and reduced signalling through the mechanistic target of rapamycin complex 1 (mTORC1) pathway. Synthesis of the metabolic transcription factor C/EBPβ-LIP is stimulated by mTORC1, which critically depends on a short upstream open reading frame (uORF) in the Cebpb-mRNA. Here, we describe that reduced C/EBPβ-LIP expression due to genetic ablation of the uORF delays the development of age-associated phenotypes in mice. Moreover, female C/EBPβΔuORF mice display an extended lifespan. Since LIP levels increase upon aging in wild type mice, our data reveal an important role for C/EBPβ in the aging process and suggest that restriction of LIP expression sustains health and fitness. Thus, therapeutic strategies targeting C/EBPβ-LIP may offer new possibilities to treat age-related diseases and to prolong healthspan.

15 February 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MZMohamad A. Zaini
Mohamad A. Zaini
CMChristine Müller
Christine Müller
TATobias Ackermann
Tobias Ackermann
JRJeanette Reinshagen
Jeanette Reinshagen
GKGertrud Kortman
Gertrud Kortman
CCCornelis F. Calkhoven
Cornelis F. Calkhoven
An important part of the beneficial effects of calorie restriction (CR) on healthspan and lifespan is mediated through regulation of protein synthesis that is under control of the mechanistic target of rapamycin complex 1 (mTORC1). As one of its activities, mTORC1 stimulates translation into the metabolic transcription factor CCAAT/Enhancer Binding Protein β (C/EBPβ) isoform Liver-specific Inhibitory Protein (LIP). Regulation of LIP expression strictly depends on a translation re-initiation event that requires a conserved cis-regulatory upstream open reading frame (uORF) in the C/EBPβ-mRNA. We showed before that suppression of LIP in mice, reflecting reduced mTORC1-signaling at the C/EBPβ level, results in CR-type of metabolic improvements. Hence, we aim to find possibilities to pharmacologically down-regulate LIP in order to induce CR-mimetic effects. We engineered a luciferase-based cellular reporter system that acts as a surrogate for C/EBPβ-mRNA translation, emulating uORF-dependent C/EBPβ-LIP expression under different translational conditions. By using the reporter system in a high-throughput screening (HTS) strategy we identified drugs that reduce LIP. The drug Adefovir Dipivoxil passed all counter assays and increases fatty acid β-oxidation in a hepatoma cell line in a LIP-dependent manner. Therefore, these drugs that suppress translation into LIP potentially exhibit CR-mimetic properties.